Patents Assigned to TiGenix, S.A.U.
  • Publication number: 20170189452
    Abstract: Provided herein are novel methods and compositions utilizing adipose tissue-derived stromal stem cells for treating fistulae.
    Type: Application
    Filed: March 23, 2017
    Publication date: July 6, 2017
    Applicants: TiGenix, S.A.U., Universidad Autónoma de Madrid
    Inventors: María Gema FERNÁNDEZ MIGUEL, Manuel Ángel GONZÁLEZ DE LA PEÑA, Rosa Ana GARCÍA CASTRO, Mariano GARCÍA ARRANZ, Damián GARCÍA OLMO
  • Publication number: 20170151284
    Abstract: The invention relates to the use of mesenchymal stromal cells (MSCs) for treating sepsis in a subject. The invention provides compositions, uses and methods for the treatment of sepsis.
    Type: Application
    Filed: June 30, 2015
    Publication date: June 1, 2017
    Applicant: TiGenix S.A.U.
    Inventors: Wilfried DALEMANS, Eleuterio LOMBARDO, Robert DEKKER
  • Publication number: 20170136065
    Abstract: The present invention provides a method for treating rheumatoid arthritis comprising the use of mesenchymal stromal cells.
    Type: Application
    Filed: June 30, 2015
    Publication date: May 18, 2017
    Applicant: TiGenix S.A.U.
    Inventors: Wilfried DALEMANS, Eleuterio LOMBARDO, Robert DEKKER
  • Publication number: 20160120910
    Abstract: The present invention provides a method for treating rheumatoid arthritis comprising the use of mesenchymal stem cells.
    Type: Application
    Filed: June 25, 2014
    Publication date: May 5, 2016
    Applicant: TiGenix S.A.U.
    Inventors: Eduardo BRAVO, Maria PASCUAL
  • Patent number: 8999709
    Abstract: Provided herein are novel methods and compositions utilizing adipose tissue-derived stromal stem cells for treating fistulae.
    Type: Grant
    Filed: May 16, 2006
    Date of Patent: April 7, 2015
    Assignees: Tigenix, S.A.U., Universidad Autonoma de Madrid
    Inventors: María Gema Fernández Miguel, Manuel Angel González de la Peña, Rosa Ana García Castro, Mariano García Arranz, Damián García Olmo
  • Publication number: 20140154274
    Abstract: The present invention provides medical uses and methods for the intralymphatic administration of cellular therapies. Further aspects of the invention provide compositions, kits and uses for the intralymphatic administration of cellular therapies.
    Type: Application
    Filed: January 12, 2012
    Publication date: June 5, 2014
    Applicants: TIGENIX NV, TIGENIX S.A.U.
    Inventors: Eleuterio Lombardo, Wilfried Dalemans
  • Patent number: 8679834
    Abstract: The present invention provides methods for the intralymphatic administration of cellular therapies. Further aspects of the invention provide compositions, kits and uses thereof related to such methods.
    Type: Grant
    Filed: July 9, 2010
    Date of Patent: March 25, 2014
    Assignee: TiGenix S.A.U
    Inventors: Eleuterio Lombardo, Dirk Büscher
  • Publication number: 20140072539
    Abstract: Provided herein are novel methods and compositions utilizing adipose tissue-derived stromal stem cells for treating fistulae.
    Type: Application
    Filed: September 3, 2013
    Publication date: March 13, 2014
    Applicants: TIGENIX, S.A.U., Universidad Autonoma de Madrid Ciudad Universitario de Cantoblanco
    Inventors: Maria Gema Fernandez Miguel, Manuel Angel Gonzalez De La Pena, Rosa Ana Garcia Castro, Mariano Garcia Arranz, Damian Garcia-Olmo
  • Publication number: 20130295672
    Abstract: The present invention provides novel stem culture compositions and methods.
    Type: Application
    Filed: September 8, 2011
    Publication date: November 7, 2013
    Applicants: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS, TiGenix, S.A.U.
    Inventors: Lourdes Planelles Carazo, Eleuterio Lombardo, Manuela Zonca